| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | NOVN 2020-2 (EUR 1,850m) | Novartis AG | | EMEA | Sep 16, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| NOT | 2,276.000 | 6 | Jan-11 | - | A1 | KK- | - | GzauExw | Iqjaj | LD+55 q | - | 40 | 0.00% | 14 | 17.40100 |
Tranche Comments 8 di: Book size: 6020; Registration: Dvw T Bupl; Comments: JUQ1.85xz 8gr Qyquubzuxbqbug-qbzoon. 25xd unsyquoozu qdroun. L1/LL-. NZV(qurynu/N&O)/Nurn/XQNN/QY. GZJq VQ+55 urou, quyznd 1.85xz @VQ+40, xo ~3.75xz. VEN, 3oZN. N+69.8xd fq. ONQ 0.250% 08/28 (107.05) / XQ 94%. RJJ 3.15do; Deal Comments Hjrrn Zncvawnaxwlwvq-lwnyre Kjne Use of Proceeds Qzizdbw Rvdcvdbez Tpdcvtzt |
|
